|
MO1-1 LIGHT-NING 2nd interim analysis: Early safety of 1L nivolumab + ipilimumab +/- chemotherapy for NSCLC in Japan |
|
|
|
Titel: |
MO1-1 LIGHT-NING 2nd interim analysis: Early safety of 1L nivolumab + ipilimumab +/- chemotherapy for NSCLC in Japan |
Auteur: |
Azuma, Koichi Imai, Hisao Kijima, Takashi Kishi, Kazuma Saito, Haruhiro Yamaguchi, Teppei Hayashi, Hidetoshi Shiraishi, Yoshimasa Fujita, Kohei Watanabe, Satoshi Kitazono, Satoru Fukuhara, Tatsuro Hataji, Osamu Toi, Yukihiro Mizutani, Hideaki Hamakawa, Yusuke Maemondo, Makoto Ohsugi, Tomoyuki Suzuki, Keisuke Horinouchi, Hidehito Ohe, Yuichiro |
Verschenen in: |
Annals of oncology |
Paginering: |
Jaargang 34 () nr. S3 pagina's S1393 |
Jaar: |
2023 |
Inhoud: |
|
Uitgever: |
European Society for Medical Oncology |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|